Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.0 added. Revision: v3.4.3 removed.SummaryDifference0.0%

- Check41 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3; no user-facing content changes are indicated.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page shows a minor site maintenance update: addition of Revision: v3.4.2 and removal of the older funding-related note (Revision: v3.4.1); no changes to core study details, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision tag to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.1%

- Check83 days agoChange DetectedA glossary display option was added and several study metadata fields were updated (e.g., Results First Posted and Last Update Posted). The older estimated fields and No FEAR Act data were removed, and the site version updated to Revision: v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.